Year-end Sale % OFF 
Abstract
Re-activation of the hepatitis B virus is very unusual, but has been described as a complication of chemotherapy. Most reported cases are related to haematological malignancies and, occasionally, to solid tumours.We report a case of hepatitis B virus re-activation resulting in fulminant hepatitis in a patient with non-small-cell lung cancer following chemotherapy with cisplatin and gemcitabine.Risk-factors associated with the re-activation were gender, age and the administration of cortico-steroids.During chemotherapy administered to patients with a history of chronic hepatitis B, care must be taken to avoid the administration of cortico-steroids as anti-emetics, and to monitor the patient's transaminase concentrations.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
